van Veldhuisen, Thijs W.
Verwiel, Madelief A. M.
Novosedlik, Sebastian https://orcid.org/0009-0005-9654-8904
Brunsveld, Luc https://orcid.org/0000-0001-5675-511X
van Hest, Jan C. M. https://orcid.org/0000-0001-7973-2404
Funding for this research was provided by:
Netherlands Ministry of education, culture and science
Article History
Received: 14 February 2024
Accepted: 19 June 2024
First Online: 28 June 2024
Competing interests
: The authors declare the following conflict of interest: L.B. is a co-founder and shareholder of Ambagon Therapeutics. The remaining authors declare no competing interests.